Neuralink’s proposal for the trademark ‘TelePathy’ and ‘Telekinesis’ is confronted with legal issues
US The patent and trademark office has rejected Neuralink’s attempt to mark the brand of TelePathy and Telekinesis products, citing plans for another person for the same trademarks.
Neuralink, a brain planting company, collaborated by Elon Mossak, gave a trademark in March. But in letters sent to Neuralink in August, the Trademark Office refuses to allow programs forward. Wisley Barry, a computer scientist and founder of technology innovation, had previously recorded business programs for telepathy in May 2023 and Telekinesis in August 2024. The prophetic is building a wearable headset to induce a clear dream, but only berry is the author of trademark programs, not methodical. (Barry refused to comment on this story.)
In response to Neuralink’s request for telepathy, the Trademark Office also refers to the trademark available for TelePathy laboratories, a TAMPA -based company that offers interactive audio and umbrella technology for jobs.
At the same time, Neuralink Musk is creating a brain and computer interface containing a device, which is planted in the skull, which collects brain activity. The company uses TelePathy to describe its first product designed to allow paralysis to work with its phones and computers only with its thoughts. Musk unveiled the name of TelePathy at the January 2024 social media post, shortly after the company was planted its first volunteer with the technology. According to the July announcement, nine people have a neuralink device. (Neuralink did not respond to the comment’s request.)
Berry and Neuralink both presented “intent” programs, allowing jobs and inventors to book trademark rights before using the brand in business. Barry’s request for TelePathy was accepted in December 2024 and for Telekinesis in August 2025, but trademarks have not been fully registered until he shows that he really uses them in business. Barry has three years to do this from acceptance, otherwise his requests will be deserted and the Neuralink request will be prioritized.
Barry has not marketed a product called TelePathy or Telekinesis, but in its business programs as “software that analyzes EEG for internal decoding for computer control or mobile devices. EEG or electroceseflogram, data is referred to as electrical activity through the skin.
The letter of the Trademark Office to Neuralink is not the final decisions. Neuralink responded to a letter on August 28 that addressed TelePathy Labs trademarks, saying that the TelePathy neuralink product probably would not be confused with TelePatics laboratories. Neuralink has been replying to Barry’s plans.
“The standard for the possibility of confusion is that if a random consumer faces both of these products, do they think they are coming from the same company?” Heather Antoine, a partner of the intellectual property in Stoel in Sacramento, California, says.
The Trademark Office considers the Neuralink response and decides whether there is a possibility of confusion. But there is still the fact that Barry has first signed up for telepathy and Telekinesis registrations. If Barry succeeds in capturing the symptoms, Neuralink will have several options. This can try to buy trademarks from Barry or negotiate on the agreement, in which Barry can agree to allow Neuralink to use these symptoms as well. This type of agreement is usually done when trademarks are likely to not confuse the consumer.
If Barry is successful in registering a telepathy, if the company continues to use it, you can complain about Neuralink.
Josh Gorben, a trademark lawyer and founder of Gerben IP in Washington, DC, says it is difficult to know how things are gone because there is a great deal of delicacy to claim trademarks. “Certainly now, the advantage is going to be another applicant,” he says, referring to Barry. “He can turn into a remarkable throat alongside neuralink for these trademarks.”
